Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.45), $0.19 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $373 thousand versus the consensus estimate of $330 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

Earnings